Wells Fargo
IRD

Wells Fargo’s Opus Genetics IRD Stock Holding History

Wells Fargo’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
52,633
+48,848
+1,291% +$228K ﹤0.01% 5157
2026
Q1 		$17.2K Sell
3,785
-238,086
-98% -$824K ﹤0.01% 5830
2025
Q4 		$486K Buy
241,871
+238,086
+6,290% +$483K ﹤0.01% 4515
2025
Q3 		$6.25K Hold
3,785
– – ﹤0.01% 6036
2025
Q2 		$3.57K Hold
3,785
– – ﹤0.01% 6136
2025
Q1 		$3.72K Buy
3,785
+1,000
+36% +$1.12K ﹤0.01% 6076
2024
Q4 		$3.31K Sell
2,785
-4
-0.1% -$5 ﹤0.01% 6125
2024
Q3 		$3.65K Hold
2,789
– – ﹤0.01% 5975
2024
Q2 		$4.27K Sell
2,789
-177
-6% -$306 ﹤0.01% 5901
2024
Q1 		$5.96K Buy
2,966
+15
+0.5% +$38 ﹤0.01% 5857
2023
Q4 		$8.88K Buy
2,951
+9
+0.3% +$27 ﹤0.01% 5864
2023
Q3 		$9.86K Buy
2,942
+22
+0.8% +$88 ﹤0.01% 5811
2023
Q2 		$12.7K Buy
2,920
+6
+0.2% +$28 ﹤0.01% 5851
2023
Q1 		$10.9K Buy
2,914
+2
+0.1% +$7 ﹤0.01% 5838
2022
Q4 		$10.3K Buy
2,912
+4
+0.1% +$11 ﹤0.01% 5540
2022
Q3 		$6K Buy
2,908
+4
+0.1% +$9 ﹤0.01% 5871
2022
Q2 		$5K Buy
2,904
+12
+0.4% +$27 ﹤0.01% 6035
2022
Q1 		$9K Buy
2,892
+2,790
+2,735% +$9.55K ﹤0.01% 6326
2021
Q4 		$0 Buy
102
+35
+52% +$140 ﹤0.01% 7938
2021
Q3 		$0 Buy
67
+63
+1,575% +$290 ﹤0.01% 7641
2021
Q2 		$0 Hold
4
– – ﹤0.01% 7576
2021
Q1 		$0 Hold
4
– – ﹤0.01% 7502
2020
Q4 		$0 Sell
4
-7
-64% -$48 ﹤0.01% 7136
2020
Q3 		$0 Hold
11
– – ﹤0.01% 7029
2020
Q2 		$0 Hold
11
– – ﹤0.01% 6940
2020
Q1 		$0 Buy
11
+6
+120% +$52 ﹤0.01% 6930
2019
Q4 		$0 Buy
5
+1
+25% +$8 ﹤0.01% 6816
2019
Q3 		$0 Hold
4
– – ﹤0.01% 6791
2019
Q2 		$0 Hold
4
– – ﹤0.01% 6668
2019
Q1 		$0 Sell
4
-8
-67% -$265 ﹤0.01% 6534
2018
Q4 		$1K Buy
12
+4
+50% +$234 ﹤0.01% 6324
2018
Q3 		$1K Hold
8
– – ﹤0.01% 6333
2018
Q2 		$1K Hold
8
– – ﹤0.01% 6274
2018
Q1 		$1K Hold
8
– – ﹤0.01% 6298
2017
Q4 		$1K Sell
8
-164
-95% -$16.7K ﹤0.01% 6284
2017
Q3 		$20K Buy
172
+152
+760% +$16.4K ﹤0.01% 5714
2017
Q2 		$3K Hold
20
– – ﹤0.01% 6012
2017
Q1 		$5K Sell
20
-5
-20% -$648 ﹤0.01% 6040
2016
Q4 		$1K Buy
25
+16
+178% +$1.3K ﹤0.01% 6187
2016
Q3 		$1K Sell
9
-3
-25% -$362 ﹤0.01% 6129
2016
Q2 		$1K Hold
12
– – ﹤0.01% 6032
2016
Q1 		$2K Buy
+12
New +$2K ﹤0.01% 6050
2015
Q4 		– Sell
-823
Closed -$205K – 6459
2015
Q3 		$205K Sell
823
-31
-4% -$8.42K ﹤0.01% 4455
2015
Q2 		$249K Sell
854
-26
-3% -$8.83K ﹤0.01% 4486
2015
Q1 		$308K Buy
880
+256
+41% +$93K ﹤0.01% 4208
2014
Q4 		$210K Buy
624
+280
+81% +$96.7K ﹤0.01% 4389
2014
Q3 		$134K Buy
344
+26
+8% +$9.36K ﹤0.01% 4530
2014
Q2 		$133K Buy
318
+15
+5% +$6.82K ﹤0.01% 4560
2014
Q1 		$157K Buy
+303
New +$164K ﹤0.01% 4453

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wells Fargo's IRD Position: Q2 2026 in Review

Wells Fargo increased its Opus Genetics (IRD) stake by 1,291% in Q2 2026, buying an estimated $228K and bringing the position to 52,633 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #5157.

Wells Fargo first reported a position in IRD in Q1 2014 and has held it in 49 quarters since. The position peaked at $486K in Q4 2025. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Wells Fargo held 52,633 shares of Opus Genetics worth $216K as of Q2 2026.
  • Wells Fargo bought 48,848 Opus Genetics shares in Q2 2026, an estimated $228K.
  • Opus Genetics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5157 holding.
  • Wells Fargo first reported a position in Opus Genetics in Q1 2014 and has held it in 49 quarters since.
  • Wells Fargo's Opus Genetics position peaked at $486K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.